Application YC di PreDxion Bio

Summer 2017Inactive

PreDxion Bio ha partecipato a Y Combinator nel batch Summer 2017 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2017
Settore: HealthcareDiagnostics
Dimensione team: 6
Stato: Inactive
Lanciata: 2017

Founder

Walker McHughFounder
Timothy CornellFounder

Cosa fa PreDxion Bio

PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.

Application YC di PreDxion Bio, ricostruita

Domanda per Y Combinator

PreDxion Bio, batch Summer 2017. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

PreDxion Bio

Describe what your company does in 50 characters or less.

Rapid, scalable diagnostic for SARS-CoV-2 and beyond

What is your company going to make? Please describe your product and what it does or will do.

We build a rapid antigen test that detects the SARS-CoV-2 spike protein from saliva, targeting asymptomatic and presymptomatic carriers. Our platform uses semiconductor fab processes allowing us to scale to tens of millions of tests in days. We originally started with sensors that monitor immune responses in critical care, now pivoting to large-scale infectious disease diagnostics.

Where do you live now, and where would the company be based after YC?

We are based in South San Francisco now and plan to remain here after YC, to stay close to biotech and semiconductor partners.

Explain your decision regarding location.

South San Francisco situates us amid biotech and diagnostics companies, and semiconductor fabs nearby for scaling manufacturing. It's critical for integrating our microfluidics and nanosensor technology with existing infrastructure.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di PreDxion Bio?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di PreDxion Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come PreDxion Bio si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva PreDxion Bio?

PreDxion Bio apparteneva al batch Summer 2017 di Y Combinator.

Chi ha fondato PreDxion Bio?

PreDxion Bio è stato fondato da Walker McHugh, Timothy Cornell.

Cosa fa PreDxion Bio?

Rapid, scalable diagnostic for SARS-CoV-2 and beyond

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di PreDxion Bio, e di ogni altro batch YC, è in YC Insights.